JP2023548399A5 - - Google Patents
Info
- Publication number
- JP2023548399A5 JP2023548399A5 JP2023527452A JP2023527452A JP2023548399A5 JP 2023548399 A5 JP2023548399 A5 JP 2023548399A5 JP 2023527452 A JP2023527452 A JP 2023527452A JP 2023527452 A JP2023527452 A JP 2023527452A JP 2023548399 A5 JP2023548399 A5 JP 2023548399A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence described
- antibody containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109814P | 2020-11-04 | 2020-11-04 | |
| US63/109,814 | 2020-11-04 | ||
| US202063113920P | 2020-11-15 | 2020-11-15 | |
| US63/113,920 | 2020-11-15 | ||
| PCT/US2021/057209 WO2022098570A1 (en) | 2020-11-04 | 2021-10-29 | Novel bifunctional multispecific antagonists capable of inhibiting multiple ligands of tgf-beta family and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548399A JP2023548399A (ja) | 2023-11-16 |
| JP2023548399A5 true JP2023548399A5 (https=) | 2024-11-08 |
Family
ID=81458297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527452A Pending JP2023548399A (ja) | 2020-11-04 | 2021-10-29 | Ｔｇｆ－ベータファミリーの複数のリガンドを阻害する能力を有する新規の二機能性多特異性アンタゴニストおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240343788A1 (https=) |
| EP (1) | EP4240388A4 (https=) |
| JP (1) | JP2023548399A (https=) |
| KR (1) | KR20230117348A (https=) |
| AU (1) | AU2021376241A1 (https=) |
| CA (1) | CA3196443A1 (https=) |
| MX (1) | MX2023004726A (https=) |
| WO (1) | WO2022098570A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025043075A1 (en) * | 2023-08-24 | 2025-02-27 | The Johns Hopkins University | Methods of treating myocardial infarction, ischemia, and ischemia reperfusion injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41920B1 (fr) * | 2015-04-06 | 2021-05-31 | Acceleron Pharma Inc | Protéines de fusion de récepteur type i et type ii à bras unique et leurs utilisations |
| EP3576773B1 (en) * | 2017-02-01 | 2023-10-18 | Acceleron Pharma Inc. | Tgf beta and actrii antagonists for use in treating leukemia |
| US12103959B2 (en) * | 2018-05-03 | 2024-10-01 | Acceleron Pharma Inc. | Multispecific binders of TGFBeta-superfamily ligands and uses thereof |
| CA3103427A1 (en) * | 2018-06-15 | 2019-12-19 | Acceleron Pharma Inc. | Bi-and tri-functional fusion proteins and uses thereof |
-
2021
- 2021-10-29 CA CA3196443A patent/CA3196443A1/en active Pending
- 2021-10-29 WO PCT/US2021/057209 patent/WO2022098570A1/en not_active Ceased
- 2021-10-29 AU AU2021376241A patent/AU2021376241A1/en active Pending
- 2021-10-29 US US18/034,499 patent/US20240343788A1/en active Pending
- 2021-10-29 MX MX2023004726A patent/MX2023004726A/es unknown
- 2021-10-29 KR KR1020237018740A patent/KR20230117348A/ko active Pending
- 2021-10-29 JP JP2023527452A patent/JP2023548399A/ja active Pending
- 2021-10-29 EP EP21889869.0A patent/EP4240388A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7438958B2 (ja) | 新規な抗体分子、その調製方法及びその使用 | |
| JP2021510710A5 (https=) | ||
| Lu et al. | Di-diabody: a novel tetravalent bispecific antibody molecule by design | |
| EP2471814B1 (en) | Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody | |
| JP2020063262A5 (https=) | ||
| JP2022515318A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2019524693A5 (https=) | ||
| JP2013507115A5 (https=) | ||
| JP2010518820A5 (https=) | ||
| JP2023527937A5 (https=) | ||
| JP2023508174A5 (https=) | ||
| JP2021512604A5 (https=) | ||
| US20240132579A1 (en) | Vegfa-binding molecules | |
| JP7737471B2 (ja) | 抗ｂｃａｍ抗体又はその抗原結合フラグメント | |
| JP2023546758A5 (https=) | ||
| JP7813704B2 (ja) | 抗ｂｃｍａ／抗４－１ｂｂ二重特異性抗体及びその用途 | |
| JP2021529524A5 (https=) | ||
| JP2023548399A5 (https=) | ||
| EP4667491A1 (en) | Anti-cntn4 antibody and uses thereof | |
| CN119866346B (zh) | 一种抗vegfa抗体或其抗原结合片段及其应用 | |
| Masuko et al. | Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein | |
| JP2025535104A (ja) | Ｂ７ｈ３／ｐｄｌ１二重特異性抗体およびその医薬組成物ならびにその使用 | |
| JP2023546759A5 (https=) | ||
| JP2023548346A5 (https=) |